0001209191-16-138764.txt : 20160826
0001209191-16-138764.hdr.sgml : 20160826
20160826135155
ACCESSION NUMBER: 0001209191-16-138764
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160824
FILED AS OF DATE: 20160826
DATE AS OF CHANGE: 20160826
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 161854160
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2016-08-24
4
M
0
6500
36.30
A
274725
D
Common Stock
2016-08-24
4
S
0
1100
96.73
D
273625
D
Common Stock
2016-08-24
4
S
0
1000
98.74
D
272625
D
Common Stock
2016-08-24
4
S
0
100
99.50
D
272525
D
Common Stock
2016-08-24
4
S
0
1500
101.21
D
271025
D
Common Stock
2016-08-24
4
S
0
2800
101.83
D
268225
D
Common Stock
13286
I
401k
Common Stock
2016-08-24
4
S
0
100
100.02
D
79100
I
Common Stock Held In Trust
Common Stock
2016-08-24
4
S
0
900
101.60
D
78200
I
Common Stock Held In Trust
Stock Option (Right to Buy)
36.30
2016-08-24
4
M
0
6500
0.00
D
2017-01-23
Common Stock
6500
131500
D
Transaction made pursuant to the holder's company approved trading plan under Rule 10b5-1.
The holder undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $96.73 (range $96.40 to $97.37).
Open market sales reported on this line occurred at a weighted average price of $98.74 (range $98.37 to $99.19).
Open market sales reported on this line occurred at a weighted average price of $101.21 (range $100.63 to $101.60).
Open market sales reported on this line occurred at a weighted average price of $101.83 (range $101.63 to $102.45).
Open market sales reported on this line occurred at a weighted average price of $101.60 (range $101.25 to $102.00).
Fully vested.
Omar White, Attorney-In-Fact
2016-08-26